Trade secret protection is becoming an increasingly critical component of life sciences IP strategy, as companies reassess the boundaries between patent protection, regulatory disclosure and confidential know-how. This roundtable will examine how organisations are structuring trade secret frameworks within their wider IP portfolio, and how legal teams are navigating the tension between disclosure requirements and long-term competitive advantage.
Speaker(s):
Marcell Komlosi
Patent Counsel
Debiopharm International SA
Agenda Track No.:
Track 3
Session Type:
General Session (Presentation)
Force Inline Description:
0